Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial

• Ashish Narayan Masurekar ,

  Contributed equally to this work with: Ashish Narayan Masurekar, Catriona A. Parker

  Affiliation Children’s Cancer Group, Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer, Manchester Academic Health Science Centre, Central Manchester University Hospitals Foundation Trust, The University of Manchester, Manchester, United Kingdom

  ⨯
• Catriona A. Parker ,

  Contributed equally to this work with: Ashish Narayan Masurekar, Catriona A. Parker

  Affiliation Children’s Cancer Group, Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer, Manchester Academic Health Science Centre, Central Manchester University Hospitals Foundation Trust, The University of Manchester, Manchester, United Kingdom

  ⨯
• Milensu Shanyinde,

  Affiliation Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Anthony V. Moorman,

  Affiliation Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom

  ⨯
• Jeremy P. Hancock,

  Affiliation Bristol Genetics Laboratory, Southmead Hospital, Bristol, United Kingdom

  ⨯
• Rosemary Sutton,

  Affiliation Children’s Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia

  ⨯
• Philip J. Ancliff,

  Affiliation Great Ormond Street Hospital, London, United Kingdom

  ⨯
• Mary Morgan,

  Affiliation Child Oncology and Haematology Centre, Southampton General Hospital, Southampton, United Kingdom

  ⨯
• Nicholas J. Goulden,

  Affiliation Great Ormond Street Hospital, London, United Kingdom

  ⨯
• Chris Fraser,

  Affiliation Queensland Children's Cancer Centre, Brisbane, Australia

  ⨯
• Peter M. Hoogerbrugge,

  Affiliation Childrens Hospital, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Dutch Childhood Oncology Group, The Hague, The Netherlands

  ⨯
• Tamas Revesz,

  Affiliation Department of Haematology-Oncology, SA Pathology at Women’s and Children’s Hospital and University of Adelaide, Adelaide, Australia

  ⨯
• Philip J. Darbyshire,

  Affiliation Department of Haematology, Birmingham Children’s Hospital, Birmingham, United Kingdom

  ⨯
• Shekhar Krishnan,

  Affiliation Paediatric Oncology, Tata Translational Cancer Research Centre, Kolkata, India

  ⨯
• Sharon B. Love,

  Affiliation Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
•  [ ... ],
• Vaskar Saha

  * E-mail: vaskar.saha@manchester.ac.uk

  Affiliation Paediatric Oncology, Tata Translational Cancer Research Centre, Kolkata, India

  ⨯
• [ view all ]
• [ view less ]